Skip to main content

TG Therapeutics, Inc.

TGTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001001316

In the last 90 days, TG Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 430 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by TG Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
1 filing
1 insider, $274.8K in total
Insiders trading
1
Net value
−$274.8K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for TG Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for TG Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Charney Laurence NDirector168,640Sep 14, 20264
Echelard YannDirector223,816Jun 15, 20262
Hoberman KennethDirector279,653Jun 15, 20261
Hume DanielDirector192,748Jun 15, 20261
Lonial SagarDirector94,061Jun 15, 20261
Weiss Michael SCEO9,778,086Jan 9, 20262
Power Sean ACFO798,111Jan 9, 20261

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 14, 2026 (view filing)5:00 PM ETSep 104 daysCharney Laurence NDirectorSSale−5.00K$54.96−$274.8K−2.9%168.6K after
Nov 25, 2025 (view filing)Nov 241 dayEchelard YannDirectorSSale−5.00K$32.57−$162.8K−2.2%223.8K after
Sep 12, 2025 (view filing)Sep 111 dayLonial SagarDirectorSSale−20.9K$32.24−$672.3K−18.1%94.1K after
Jun 16, 2025 (view filing)Jun 133 daysEchelard YannDirectorSSale−10.0K$36.94−$369.4K−4.2%228.8K after
Jan 7, 2025 (view filing)Jan 3-64 daysPower Sean ACFOSSale−21.4K$29.46−$629.3K−3.1%660.6K after2 lots
Nov 12, 2024 (view filing)Nov 111 dayLonial SagarDirectorSSale−5.00K$30.44−$152.2K−4.8%100.2K after
Nov 12, 2024 (view filing)Nov 111 dayCharney Laurence NDirectorSSale−25.0K$30.20−$755.0K−10.5%212.5K after
Nov 7, 2024 (view filing)Nov 52 daysEchelard YannDirectorSSale−20.0K$24.48−$489.6K−8.2%224.1K after
Jun 20, 2024 (view filing)Jun 17-203 daysLonial SagarDirectorSSale−25.9K$16.69−$432.9K−19.8%105.2K after2 lots
Mar 15, 2024 (view filing)Mar 132 daysLonial SagarDirectorSSale−5.00K$15.94−$79.7K−4.4%108.9K after
Mar 13, 2024 (view filing)Mar 121 dayCharney Laurence NDirectorSSale−22.0K$15.97−$351.3K−9.3%215.2K after
Jan 8, 2024 (view filing)Jan 53 daysCharney Laurence NDirectorSSale−17.5K$19.03−$333.0K−6.9%237.2K after
Jan 5, 2024 (view filing)Jan 32 daysPower Sean ACFOSSale−47.9K$16.91−$809.4K−7.3%607.0K after
Aug 14, 2023 (view filing)Aug 113 daysWeiss Michael SCEO and PresidentPPurchase+100.0K$10.13+$1.01M+0.8%12.1M after
Jun 26, 2023 (view filing)Jun 233 daysLonial SagarDirectorSSale−34.9K$23.37−$814.5K−27.1%93.9K after
Jun 5, 2023 (view filing)Jun 23 daysPower Sean AChief Financial OfficerSSale−73.6K$26.70−$1.97M−10.1%654.8K after
Jan 6, 2023 (view filing)Jan 6Same dayEchelard YannDirectorPPurchase+9.00K$10.64+$95.8K+4.7%201.8K after
Jan 6, 2023 (view filing)Jan 42 daysCharney Laurence NDirectorSSale−30.0K$11.10−$333.0K−11.3%234.7K after
Jan 7, 2022 (view filing)Jan 4-53 daysLatePower Sean ACFO, Secretary and TreasurerSSale−85.0K$19.10−$1.62M−13.0%568.5K after2 lots
Jan 7, 2022 (view filing)Jan 4-53 daysLateWeiss Michael SCEO and PresidentSSale−68.2K$18.80−$1.28M−0.6%11.0M after2 lots